Interim Measure Offers Clarity On E-Labeling In Canada
Executive Summary
While the Canadian regulator finalizes its policy on using electronic labeling, it has issued an interim order that explains what information companies can include in electronic platforms that are linked to a drug’s physical label.
You may also be interested in...
Canada Consults On Electronic Labels To Supplement Prescription Drug Info
Health Canada has noted a growing interest among companies to incorporate in their product labels a link to websites/apps to offer additional information about prescription drugs. These electronic platforms are regulated as electronic labels and must be approved prior to distribution.
Roche’s Eye Drug Scores First UK Approval Under Access Consortium
The UK MHRA has approved its first drug under an international work-sharing initiative that also includes regulators from Australia, Canada, Singapore and Switzerland.
UK MHRA Specifies Eligibility For Consultancy Firms To Monitor GMP, GDP Compliance
Consultancy firms must have at least five years of experience in carrying out independent GMP or GDP audits if they want to apply to become a “compliance monitor” under a new MHRA scheme to keep track of drug companies that fail to comply with GMP/GDP requirements.